Karen L. Syrjala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Karen L. Syrjala has a total of 296 co-authors. Here are the top co-authors by number of shared publications:
- Biljana Gigic
Department of General, Visceral, and Transplantation Surgery Heidelberg University Hospital Heidelberg Germany
11 shared publications - Cornelia M. Ulrich
Huntsman Cancer Institute and Department of Population Health Sciences, University of Utah, Salt Lake City, Utah
11 shared publications - Adetunji T. Toriola
Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, Missouri
10 shared publications - Alexis Ulrich
Department of General, Visceral and Transplantation Surgery, University of Heidelberg, 69117 Heidelberg, Germany
10 shared publications - Christopher I. Li
Public Health Sciences Division Fred Hutchinson Cancer Center Seattle Washington USA
10 shared publications - Claire Jungyoun Han
Center for Healthy Aging, Self-Management and Complex Care, College of Nursing, The Ohio State University, Columbus, OH 43210, USA
10 shared publications
Latest Publications
- Open Access
- 21 September 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e111094
Correction: Protocol for a Sequential Multiple Assignment Randomized Trial to Improve Physical Activity and Diet Quality in Survivors of Cancer
- 21 September 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e111094
Open AccessCorrection: Protocol for a Sequential Multiple Assignment Randomized Trial to Improve Physical Activity and Diet Quality in Survivors of Cancer
- Open Access
- 13 August 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e104572
Protocol for a Sequential Multiple Assignment Randomized Trial to Improve Physical Activity and Diet Quality in Survivors of Cancer
Background: Survivors of childhood cancer have an increased risk of cardiovascular disease (CVD), but that risk may be reduced by healthy lifestyle behaviors. Objective: Using a sequential multiple assignment randomized trial (SMART) design, this study aims to test different approaches to improve physical activity (PA) and diet quality among long-term survivors of cancer at increased risk of CVD over a 12-month period. The primary study outcomes are sedentary time and Healthy Eating Index (HEI) scores. Methods: Participants were recruited from the Childhood Cancer Survivor Study cohort, with eligibility defined as current age of 18 to 54 years and at least one of three self-reported criteria: (1) 2 . Eligible participants completed baseline surveys, including a food frequency questionnaire, and had PA measured by research-grade accelerometry, and were then randomized to one of three conditions: (1) control, (2) clinician-guided action plan (sessions with the study provider every 2 months), or (3) mobile health–supported goal setting (weekly PA and monthly diet goals based on PA and diet tracker feedback). Following SMART principles, all participants’ PA levels and HEI scores were reassessed after 3 months; participants from the 2 intervention groups who did not achieve ≥20-minute per day reduction in sedentary time or a ≥4-point increase in HEI score were classified as nonresponders and rerandomized to the alternative intervention or a more intensive lifestyle coaching intervention (weekly sessions with a study health coach). Intervention participants then entered a less intensive maintenance phase from months 7 to 12. All participants’ PA levels and HEI scores were reassessed at 12 months. The target sample size was 375 participants, with 95 participants in the control group and 140 participants in each of the initial intervention groups, which will allow the study to detect changes of 0.35 SD (approximately 30 minutes per day) in sedentary time and 0.41 SD (approximately 4 points) in HEI score between the control and intervention groups (combined). Secondary analyses will test whether there are efficacy differences across intervention strategies, and which intervention sequences are associated with the greatest reduction in sedentary time and improvements in diet quality. Results: From April 2022 to August 2025, the trial completed recruitment and randomized 374 participants out of 2268 approached. The last participant in this ongoing trial is expected to complete all procedures by the end of 2026, after which the final analyses will be conducted and the results will be reported. Conclusions: Future findings will inform whether any of these intervention strategies (and/or their combinations) can improve PA levels and diet quality in survivors of cancer at increased risk of CVD.
- 13 August 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e104572
Open AccessProtocol for a Sequential Multiple Assignment Randomized Trial to Improve Physical Activity and Diet Quality in Survivors of Cancer
Background: Survivors of childhood cancer have an increased risk of cardiovascular disease (CVD), but that risk may be reduced by healthy lifestyle behaviors. Objective: Using a sequential multiple assignment randomized trial (SMART) design, this study aims to test different approaches to improve physical activity (PA) and diet quality among long-term survivors of cancer at increased risk of CVD over a 12-month period. The primary study outcomes are sedentary time and Healthy Eating Index (HEI) scores. Methods: Participants were recruited from the Childhood Cancer Survivor Study cohort, with eligibility defined as current age of 18 to 54 years and at least one of three self-reported criteria: (1) 2 . Eligible participants completed baseline surveys, including a food frequency questionnaire, and had PA measured by research-grade accelerometry, and were then randomized to one of three conditions: (1) control, (2) clinician-guided action plan (sessions with the study provider every 2 months), or (3) mobile health–supported goal setting (weekly PA and monthly diet goals based on PA and diet tracker feedback). Following SMART principles, all participants’ PA levels and HEI scores were reassessed after 3 months; participants from the 2 intervention groups who did not achieve ≥20-minute per day reduction in sedentary time or a ≥4-point increase in HEI score were classified as nonresponders and rerandomized to the alternative intervention or a more intensive lifestyle coaching intervention (weekly sessions with a study health coach). Intervention participants then entered a less intensive maintenance phase from months 7 to 12. All participants’ PA levels and HEI scores were reassessed at 12 months. The target sample size was 375 participants, with 95 participants in the control group and 140 participants in each of the initial intervention groups, which will allow the study to detect changes of 0.35 SD (approximately 30 minutes per day) in sedentary time and 0.41 SD (approximately 4 points) in HEI score between the control and intervention groups (combined). Secondary analyses will test whether there are efficacy differences across intervention strategies, and which intervention sequences are associated with the greatest reduction in sedentary time and improvements in diet quality. Results: From April 2022 to August 2025, the trial completed recruitment and randomized 374 participants out of 2268 approached. The last participant in this ongoing trial is expected to complete all procedures by the end of 2026, after which the final analyses will be conducted and the results will be reported. Conclusions: Future findings will inform whether any of these intervention strategies (and/or their combinations) can improve PA levels and diet quality in survivors of cancer at increased risk of CVD.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study
Supplementary Table S3 shows the Cancer and Treatment Distress scores 12 months after surgery by study center.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study
Supplementary Table S3 shows the Cancer and Treatment Distress scores 12 months after surgery by study center.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study
Supplementary Figure S2 shows pre-surgery and 12-month biomarker concentrations correlated with the CTXD 12 months after surgery at Heidelberg.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study
Supplementary Figure S2 shows pre-surgery and 12-month biomarker concentrations correlated with the CTXD 12 months after surgery at Heidelberg.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study
Supplementary Table S4 shows the associations of doubling of pre-surgery biomarkers with Cancer and Treatment Distress overall score and subscores by study center.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study
Supplementary Table S4 shows the associations of doubling of pre-surgery biomarkers with Cancer and Treatment Distress overall score and subscores by study center.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study
Supplementary Figure S1 shows pre-surgery and 12-month biomarker concentrations correlated with the CTXD 12 months after surgery at Huntsman Cancer Institute.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study
Supplementary Figure S1 shows pre-surgery and 12-month biomarker concentrations correlated with the CTXD 12 months after surgery at Huntsman Cancer Institute.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study
Supplementary Table S5 shows the p-values for heterogeneity test in the associations of pre-surgery biomarkers with Cancer and Treatments Distress between study sites.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study
Supplementary Table S5 shows the p-values for heterogeneity test in the associations of pre-surgery biomarkers with Cancer and Treatments Distress between study sites.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study
Supplementary Table S2 shows the geometric means of pre-surgery biomarkers stratified by study center.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study
Supplementary Table S2 shows the geometric means of pre-surgery biomarkers stratified by study center.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study
Supplementary Table S6 shows the odds ratios (95% CI) for associations with pre-surgery biomarkers in tertiles concentrations with Cancer and Treatment Distress.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study
Supplementary Table S6 shows the odds ratios (95% CI) for associations with pre-surgery biomarkers in tertiles concentrations with Cancer and Treatment Distress.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study
Supplementary Table S1 shows the pre-surgery characteristics of patients recruited into the ColoCare Study by study center.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study
Supplementary Table S1 shows the pre-surgery characteristics of patients recruited into the ColoCare Study by study center.